As one of the joint undertakings under Horizon Europe, a draft Strategic Research & Innovation Agenda (SRIA) for the Innovative Health Initiative (IHI) has been published on the European Commission (EC) website.
IHI will build on the successes of and lessons learnt from the Innovative Medicines Initiative (IMI). The goal of IHI is to help create an EU-wide health research and innovation ecosystem that facilitates the translation of scientific knowledge into tangible innovations, with a total proposed budget of €2.4 billion.
The Commission welcomes feedback on the draft SRIA from members of the rare disease community. The draft SRIA will become a binding document of the IHI upon formal establishment and adoption by the Governing Board. Interested parties can send feedback by email: RTD-IHI [at] ec.europa.eu.
More information here: https://ec.europa.eu/info/research-and-innovation/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/european-partnerships-horizon-europe/candidates-european-partnerships-health_en (section titled “European Partnership for Innovative Health”)